UBS ASSET MANAGEMENT AMERICAS LLC - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$26,589,000
+190.7%
10,000,000
+100.0%
0.03%
+188.9%
Q4 2014$9,148,000
-62.3%
5,000,000
-50.0%
0.01%
-62.5%
Q3 2014$24,266,000
+23.8%
10,000,0000.0%0.02%
+20.0%
Q2 2014$19,604,000
+17.1%
10,000,0000.0%0.02%
+11.1%
Q1 2014$16,743,000
+8.3%
10,000,000
-4.8%
0.02%0.0%
Q4 2013$15,455,000
+32.9%
10,500,000
+10.5%
0.02%
+28.6%
Q3 2013$11,631,000
+2.2%
9,500,0000.0%0.01%
-6.7%
Q2 2013$11,377,0009,500,0000.02%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 36,001,000$95,697,00016.53%
CAPSTONE INVESTMENT ADVISORS, LLC 145,320,992$386,133,0006.28%
Verition Fund Management LLC 18,500,000$49,268,0005.72%
PIPER SANDLER & CO. 3,750,000$9,968,0004.14%
BERKLEY W R CORP 25,881,000$68,886,0003.58%
WOLVERINE ASSET MANAGEMENT LLC 31,256,000$83,048,0001.66%
TT INTERNATIONAL 760,000$2,020,0001.41%
FARALLON CAPITAL MANAGEMENT LLC 31,014,000$82,372,0001.20%
CSS LLC/IL 8,300,000$22,057,0001.12%
SG Americas Securities, LLC 370,000$98,536,0000.59%
View complete list of SALIX PHARMACEUTICALS INC shareholders